- Home
- PEB vs NBTX Comparison
PEB vs NBTX Comparison
Compare PEB & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEB
- NBTX
- Stock Information
- Founded
- PEB 2009
- NBTX 2003
- Country
- PEB United States
- NBTX France
- Employees
- PEB N/A
- NBTX N/A
- Industry
- PEB Real Estate Investment Trusts
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- PEB Real Estate
- NBTX Health Care
- Exchange
- PEB Nasdaq
- NBTX Nasdaq
- Market Cap
- PEB 1.2B
- NBTX 1.3B
- IPO Year
- PEB 2009
- NBTX 2020
- Fundamental
- Price
- PEB $10.44
- NBTX $20.40
- Analyst Decision
- PEB Hold
- NBTX Strong Buy
- Analyst Count
- PEB 8
- NBTX 1
- Target Price
- PEB $12.29
- NBTX $8.00
- AVG Volume (30 Days)
- PEB 1.8M
- NBTX 135.2K
- Earning Date
- PEB 11-05-2025
- NBTX 09-30-2025
- Dividend Yield
- PEB 0.37%
- NBTX N/A
- EPS Growth
- PEB N/A
- NBTX N/A
- EPS
- PEB N/A
- NBTX N/A
- Revenue
- PEB $1,469,933,000.00
- NBTX $11,930,711.00
- Revenue This Year
- PEB $2.11
- NBTX N/A
- Revenue Next Year
- PEB $2.83
- NBTX $114.97
- P/E Ratio
- PEB N/A
- NBTX N/A
- Revenue Growth
- PEB 2.00
- NBTX N/A
- 52 Week Low
- PEB $7.42
- NBTX $2.76
- 52 Week High
- PEB $15.12
- NBTX $30.35
- Technical
- Relative Strength Index (RSI)
- PEB 38.50
- NBTX 50.50
- Support Level
- PEB $10.56
- NBTX $17.37
- Resistance Level
- PEB $11.26
- NBTX $28.51
- Average True Range (ATR)
- PEB 0.37
- NBTX 1.80
- MACD
- PEB -0.02
- NBTX -1.12
- Stochastic Oscillator
- PEB 26.05
- NBTX 36.25
About PEB Pebblebrook Hotel Trust of Beneficial Interest
Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,933 rooms across 46 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.